EE368 Economic Burden Utilities and Cost-Effectiveness of the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Literature Review (SLR)
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.752
https://www.valueinhealthjournal.com/article/S1098-3015(25)03309-1/fulltext
Title :
EE368 Economic Burden Utilities and Cost-Effectiveness of the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Literature Review (SLR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03309-1&doi=10.1016/j.jval.2025.09.752
First page :
Section Title :
Open access? :
No
Section Order :
10326